Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Oct 31, 2016 | $24.7B |
| FY2017, ended Oct 31, 2017 | $3.56B |
| FY2018, ended Oct 31, 2018 | $37.5B |
| FY2019, ended Oct 31, 2019 | $25.2B |
| FY2020, ended Oct 31, 2020 | $23.2B |
| FY2021, ended Oct 31, 2021 | $32.8B |
| FY2022, ended Oct 31, 2022 | $27.1B |
| FY2023, ended Oct 31, 2023 | $26.1B |
| FY2024, ended Oct 31, 2024 | $33.3B |
| FY2025, ended Oct 31, 2025 | $25.4B |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $24.6B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Oct 31, 2016 | $48.2B |
| FY2017, ended Oct 31, 2017 | $52.1B |
| FY2018, ended Oct 31, 2018 | $58.5B |
| FY2019, ended Oct 31, 2019 | $58.8B |
| FY2020, ended Oct 31, 2020 | $56.6B |
| FY2021, ended Oct 31, 2021 | $63.5B |
| FY2022, ended Oct 31, 2022 | $62.9B |
| FY2023, ended Oct 31, 2023 | $53.7B |
| FY2024, ended Oct 31, 2024 | $53.6B |
| FY2025, ended Oct 31, 2025 | $55.3B |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $59.2B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Oct 31, 2016 | $2.50B | $2.82B |
| FY2017, ended Oct 31, 2017 | $2.53B | $3.27B |
| FY2018, ended Oct 31, 2018 | $5.33B | $3.98B |
| FY2019, ended Oct 31, 2019 | $3.15B | $3.98B |
| FY2020, ended Oct 31, 2020 | $2.81B | $3.74B |
| FY2021, ended Oct 31, 2021 | $6.54B | $5.83B |
| FY2022, ended Oct 31, 2022 | $3.13B | $3.70B |
| FY2023, ended Oct 31, 2023 | $3.26B | $2.98B |
| FY2024, ended Oct 31, 2024 | $2.77B | $3.16B |
| FY2025, ended Oct 31, 2025 | $2.53B | $2.80B |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $2.45B | $3.88B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Oct 31, 2016 | $6.29B |
| FY2017, ended Oct 31, 2017 | $7.00B |
| FY2018, ended Oct 31, 2018 | $5.17B |
| FY2019, ended Oct 31, 2019 | $4.54B |
| FY2020, ended Oct 31, 2020 | $4.86B |
| FY2021, ended Oct 31, 2021 | $4.30B |
| FY2022, ended Oct 31, 2022 | $3.15B |
| FY2023, ended Oct 31, 2023 | $3.11B |
| FY2024, ended Oct 31, 2024 | $3.24B |
| FY2025, ended Oct 31, 2025 | $3.69B |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $4.17B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Oct 31, 2016 | $6.80B |
| FY2017, ended Oct 31, 2017 | $8.81B |
| FY2018, ended Oct 31, 2018 | $6.93B |
| FY2019, ended Oct 31, 2019 | $5.20B |
| FY2020, ended Oct 31, 2020 | $6.30B |
| FY2021, ended Oct 31, 2021 | $8.01B |
| FY2022, ended Oct 31, 2022 | $11.2B |
| FY2023, ended Oct 31, 2023 | $9.66B |
| FY2024, ended Oct 31, 2024 | $9.80B |
| FY2025, ended Oct 31, 2025 | $9.78B |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $9.16B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 47.1% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Oct 31, 2016 | 1.71B |
| FY2017, ended Oct 31, 2017 | 165M |
| FY2018, ended Oct 31, 2018 | 1.55B |
| FY2019, ended Oct 31, 2019 | 1.45B |
| FY2020, ended Oct 31, 2020 | 1.29B |
| FY2021, ended Oct 31, 2021 | 1.08B |
| FY2022, ended Oct 31, 2022 | 982M |
| FY2023, ended Oct 31, 2023 | 991M |
| FY2024, ended Oct 31, 2024 | 938M |
| FY2025, ended Oct 31, 2025 | 918M |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | 902M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Oct 31, 2016 | $1.16B | $182M |
| FY2017, ended Oct 31, 2017 | $1.41B | $224M |
| FY2018, ended Oct 31, 2018 | $2.56B | $268M |
| FY2019, ended Oct 31, 2019 | $2.40B | $297M |
| FY2020, ended Oct 31, 2020 | $3.11B | $278M |
| FY2021, ended Oct 31, 2021 | $6.25B | $330M |
| FY2022, ended Oct 31, 2022 | $4.30B | $343M |
| FY2023, ended Oct 31, 2023 | $100M | $438M |
| FY2024, ended Oct 31, 2024 | $2.10B | $452M |
| FY2025, ended Oct 31, 2025 | $850M | $522M |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $1.23B | $479M |
Valuation
At current price- Market Cap
- $30.3B
- P/E
- 12.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.5×
- Price / Book
- n/m. Market cap / shareholders' equity
- EV / EBITDA
- 8.5×
Growth
Trailing 12 months- Revenue (TTM)
- $59.2B
- Revenue Growth YoY
- 8.1%
- Revenue CAGR 3Y
- −4.2%
- Revenue CAGR 5Y
- −0.5%
- EPS Growth YoY
- −4.7%
- Net Income Growth YoY
- −7.2%
Profitability
Trailing 12 months- Gross Margin
- 19.9%
- Operating Margin
- 5.4%
- Net Margin
- 4.1%
- FCF Margin
- 6.6%
- Return on Equity
- n/m. Net income (TTM) / average equity
Earnings
Trailing 12 months- Net Income
- $2.45B
- EPS (diluted)
- $2.62
- EBITDA
- $4.15B
- Operating Income
- $3.22B
Balance Sheet
As of Jul 31, 2026- Cash and cash equivalents
- $4.17B
- Total Debt
- $9.16B
- Net Debt
- $4.99B
- Total Assets
- $45.7B
- Total Liabilities
- $45.8B
- Shareholders' Equity
- −$92.0M
Cash Flow
Trailing 12 months- Operating Cash Flow
- $4.67B
- Capital Expenditure
- $787M
- Free Cash Flow
- $3.88B
Dividends and risk
Last 12 months- Dividend Yield
- 3.6%
- Dividend / Share
- $1.20
- Beta (5Y)
- 1.17
Every ratio is calculated from the company’s reported figures.